Novolog (Pharm-Up 1966) TASE:NVLG 주식 보고서 Novolog (Pharm-Up 1966) Ltd
TASE:NVLG 주식 보고서
NVLG 주식 개요 Novolog(Pharm-Up 1966) Ltd는 이스라엘에서 의료 서비스를 제공합니다. 자세한 내용
Novolog (Pharm-Up 1966) Ltd 경쟁사 가격 내역 및 성능
다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Novolog (Pharm-Up 1966) 과거 주가 현재 주가 ₪1.57 52주 최고치 ₪1.70 52주 최저치 ₪1.27 베타 0.36 11개월 변경 7.76% 3개월 변경 사항 11.66% 1년 변경 사항 -0.44% 33년 변화 -46.58% 5년 변화 -5.14% IPO 이후 변화 -3.68%
최근 뉴스 및 업데이트
Novolog (Pharm-Up 1966) Ltd to Report Q3, 2024 Results on Nov 20, 2024 Nov 04
Upcoming dividend of ₪0.029 per share Aug 27
Second quarter 2024 earnings released: EPS: ₪0.026 (vs ₪0.023 in 2Q 2023) Aug 22
Novolog (Pharm-Up 1966) Ltd to Report Q2, 2024 Results on Sep 04, 2024 Aug 20 Novolog (Pharm-Up 1966) Ltd, Annual General Meeting, Aug 05, 2024 Jul 02
First quarter 2024 earnings released: EPS: ₪0.024 (vs ₪0.02 loss in 1Q 2023) May 21 더 많은 업데이트 보기
Novolog (Pharm-Up 1966) Ltd to Report Q3, 2024 Results on Nov 20, 2024 Nov 04
Upcoming dividend of ₪0.029 per share Aug 27
Second quarter 2024 earnings released: EPS: ₪0.026 (vs ₪0.023 in 2Q 2023) Aug 22
Novolog (Pharm-Up 1966) Ltd to Report Q2, 2024 Results on Sep 04, 2024 Aug 20 Novolog (Pharm-Up 1966) Ltd, Annual General Meeting, Aug 05, 2024 Jul 02
First quarter 2024 earnings released: EPS: ₪0.024 (vs ₪0.02 loss in 1Q 2023) May 21
Novolog (Pharm-Up 1966) Ltd to Report Q1, 2024 Results on May 21, 2024 May 14
Full year 2023 earnings released: ₪0.082 loss per share (vs ₪0.094 profit in FY 2022) Mar 27
Novolog (Pharm-Up 1966) Ltd to Report Q4, 2023 Results on Mar 26, 2024 Mar 06
New minor risk - Share price stability Feb 10
Third quarter 2023 earnings released: EPS: ₪0.001 (vs ₪0.02 in 3Q 2022) Nov 22
Estimating The Fair Value Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) Nov 05
Investor sentiment improves as stock rises 17% Nov 05
Second quarter 2023 earnings released: EPS: ₪0.023 (vs ₪0.024 in 2Q 2022) Aug 23
Be Wary Of Novolog (Pharm-Up 1966) (TLV:NVLG) And Its Returns On Capital Jul 25
First quarter 2023 earnings released: ₪0.02 loss per share (vs ₪0.024 profit in 1Q 2022) Jun 01
Investor sentiment deteriorates as stock falls 15% Mar 30
Full year 2022 earnings released: EPS: ₪0.094 (vs ₪0.084 in FY 2021) Mar 21
Investor sentiment deteriorates as stock falls 17% Feb 26
Novolog (Pharm-Up 1966) Ltd to Report Q4, 2022 Results on Mar 20, 2023 Feb 07
Investor sentiment deteriorates as stock falls 15% Jan 30
Novolog (Pharm-Up 1966) Ltd Appoints Tami Gottlieb as an Independent Non-Executive Director Jan 17
Third quarter 2022 earnings released: EPS: ₪0.02 (vs ₪0.02 in 3Q 2021) Nov 18
Insufficient new directors Nov 16
Novolog (Pharm-Up 1966) Ltd to Report Q3, 2022 Results on Nov 16, 2022 Nov 02
Second quarter 2022 earnings released: EPS: ₪0.024 (vs ₪0.02 in 2Q 2021) Aug 14
Insufficient new directors Aug 01
Novolog (Pharm-Up 1966) Ltd to Report Q2, 2022 Results on Aug 10, 2022 Jul 28
Insufficient new directors Jul 02
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind May 22
Novolog (Pharm-Up 1966) Ltd to Report Q1, 2022 Results on May 18, 2022 May 19
Investor sentiment improved over the past week Apr 03
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Mar 17
Novolog (Pharm-Up 1966) Ltd to Report Q4, 2021 Results on Mar 14, 2022 Feb 25
Third quarter 2021 earnings released: EPS ₪0.022 (vs ₪0.021 in 3Q 2020) Nov 21
I Ran A Stock Scan For Earnings Growth And Novolog (Pharm-Up 1966) (TLV:NVLG) Passed With Ease May 07
Read This Before Buying Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) For Its Dividend Apr 14
Novolog (Pharm-Up 1966)'s (TLV:NVLG) Earnings Are Of Questionable Quality Mar 24
Upcoming dividend of ₪0.032 per share Mar 23
Full year 2020 earnings released: EPS ₪0.086 (vs ₪0.026 in FY 2019) Mar 23
Novolog (Pharm-Up 1966) Ltd to Report Fiscal Year 2020 Results on Mar 17, 2021 Mar 17
Novolog (Pharm-Up 1966) Ltd's (TLV:NVLG) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? Mar 09
How Much Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) Do Insiders Own? Feb 15
New 90-day low: ₪2.76 Feb 01
Update: Novolog (Pharm-Up 1966) (TLV:NVLG) Stock Gained 88% In The Last Three Years Jan 25
Novolog (Pharm-Up 1966) Ltd announced that it has received ILS 119.999999 million in funding Dec 31
How Much Is Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) CEO Getting Paid? Dec 29
With EPS Growth And More, Novolog (Pharm-Up 1966) (TLV:NVLG) Is Interesting Dec 08
Third quarter 2020 earnings released: EPS ₪0.021 Nov 28
Market bids up stock over the past week Nov 18
New 90-day high: ₪3.20 Nov 17
New 90-day high - ₪3.09 Jul 20 주주 수익률 NVLG IL Healthcare IL 마켓 7D 4.6% 4.1% 3.5% 1Y -0.4% 17.2% 29.1%
전체 주주 수익률 보기
수익률 대 산업: NVLG 지난 1년 동안 17.2 %를 반환한 IL Healthcare 업계보다 저조한 성과를 냈습니다.
수익률 대 시장: NVLG 지난 1년 동안 29.1 %를 반환한 IL 시장보다 저조한 성과를 냈습니다.
가격 변동성 Is NVLG's price volatile compared to industry and market? NVLG volatility NVLG Average Weekly Movement 4.2% Healthcare Industry Average Movement 3.5% Market Average Movement 4.0% 10% most volatile stocks in IL Market 7.5% 10% least volatile stocks in IL Market 2.8%
안정적인 주가: NVLG 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.
시간에 따른 변동성: NVLG 의 주간 변동성 ( 4% )은 지난 1년 동안 안정적인 모습을 보였습니다.
회사 소개 Novolog(Pharm-Up 1966)는 이스라엘에서 의료 서비스를 제공합니다. 이 회사는 세 개의 사업부로 운영됩니다: 물류, 의료 서비스, 디지털입니다. 물류 사업부는 의약품 및 의료 제품의 수입 및 유통, 임상시험 및 관련 서비스의 물류, 고객에게 제약 서비스 제공, 소모성 의료 장비의 멸균 및 검증 프로세스를 담당하고 있습니다.
자세히 보기 Novolog (Pharm-Up 1966) Ltd 기본 사항 요약 Novolog (Pharm-Up 1966) 의 수익과 매출은 시가총액과 어떻게 비교하나요? NVLG 기본 통계 시가총액 ₪801.83m 수익(TTM ) -₪17.54m 수익(TTM ) ₪1.68b
수익 및 수익 최신 수익 보고서의 주요 수익성 통계(TTM) NVLG 손익 계산서(TTM ) 수익 ₪1.68b 수익 비용 ₪1.51b 총 이익 ₪173.56m 기타 비용 ₪191.10m 수익 -₪17.54m
주당 순이익(EPS) -0.034 총 마진 10.31% 순이익 마진 -1.04% 부채/자본 비율 0.03%
NVLG 의 장기적인 성과는 어땠나요?
과거 실적 및 비교 보기 Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}